Weight loss results vary by individual and can not be guaranteed
Skoulidis F, Arbour KC, Hellmann MD, Patil P, Marmarelis ME, Owen D, Swad MM, Murray J, Levy B, Hellyer J, Gainor JF, Stewart T, Goldberg S, Dimou A, Bestvina C, Cummings AL, Elamin YY, Lam VK, Zhang J, Shu CA, Riess JW, B lakely C Pecot C, Mezquita L, Tabbo F, Sacher A, Scheffler M, Bicciuti B, Venkatraman D, Rizvi H, Liu C Johnston RP, Ni Y, Azok J, Kier M, Katz S, Davies K, Segal J, Ritterhouse L, Shaish H, Laroix L, Memmott RM, Madrigal JR, Goldman JW, Lau S, Carter B, Woodcock M, Roth JA, Swisher SG , Leighl N, Wolf J, Scagliotti GV, Planchard D, Besse B, Bivona T, Gandara DR, Garon EB, Rizvi N, Camidge R, Schalper K, Herbst RS, Shaw A, Neal J, Wakelee HA, Brahmer J, Janne P, Carbone DP, Aggarwal C, Pennell N, Rudin C, Papadimitrakopoulou V, Heymach JV
Rhonda Patrick: Well the enzyme that does that in your brain is called tryptophan hydroxylase 2, and it's activated by vitamin D
4 Materials and methods 4.1 Cell culture and in vivo experiments 4.1.1 Cell lines Four human NB cell lines were used in this paper: Be(2)-C (MNA), IMR5-/75-shMYCN (29) (MNA, doxycycline-inducible shRNA targeting MYCN, resulting in MYCN downregulation), IMR-32 (MNA), and SH-SY5Y/6TR(EU)/pTrex-Dest-30/MYCN (non-MNA, doxycycline-inducible transgene, resulting in MYCN overexpression)
